Inventor · disambiguated record
Drazen Ostovic
Also filed as: OSTOVIC DRAZEN
18 granted patents·9 pending applications·96 citations·filing 1996–2025
93Inventor score
Files withITERION THERAPEUTICS INC10CENTREXION THERAPEUTICS CORP8MERCK & CO INC3BAK ANNETTE1BOARDMAN DAVID1
Top patents by PatentIndex Score
27 records- 0196US11344516B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2020·Granted May 31, 2022·3 cites·32 claims
- 0296US10493047B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Dec 3, 2019·8 cites·30 claims
- 0395US10772853B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Sep 15, 2020·5 cites·30 claims
- 0495US10765649B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Sep 8, 2020·5 cites·30 claims
- 0594US11000490B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted May 11, 2021·4 cites·13 claims
- 0689US2024423931A1Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0788US11602501B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2021·Granted Mar 14, 2023·1 cites·22 claims
- 0888US11136307B1Crystalline form of tegavivint, method of preparation, and use thereofITERION THERAPEUTICS INC·Filed 2020·Granted Oct 5, 2021·2 cites·15 claims
- 0984US12491162B2Formulations of tegavivintITERION THERAPEUTICS INC·Filed 2024·Granted Dec 9, 2025·0 cites·17 claims
- 1084US12208166B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2023·Granted Jan 28, 2025·0 cites·26 claims
- 1182US11992470B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2022·Granted May 28, 2024·0 cites·20 claims
- 1278US11964054B2Formulations of tegavivintITERION THERAPEUTICS INC·Filed 2023·Granted Apr 23, 2024·0 cites·16 claims
- 1378US2025263391A1Crystalline form of tegavivint, method of preparation, and use thereofITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1474US11793759B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·0 cites·27 claims
- 1574US5849726AAnhydrous alendronate monosodium salt formulationsMERCK & CO INC·Filed 1996·Granted Dec 15, 1998·40 cites·7 claims
- 1672US11571388B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·0 cites·21 claims
- 1771US12297185B2Crystalline form of tegavivint, method of preparation, and use thereofITERION THERAPEUTICS INC·Filed 2021·Granted May 13, 2025·0 cites·20 claims
- 1871US2025152515A1Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1969US2020206166A1Methods and compositions for treatment of pain using capsaicinCENTREXION THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 2062US6008207AAnhydrous alendronate monosodium salt formulationsMERCK & CO INC·Filed 1998·Granted Dec 28, 1999·26 cites·4 claims
- 2154US2023365564A1Cocrystals of an adenosine a2b receptor antagonistTEON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2247US2008051453A1Sorbic acid analog co-crystalsBAK ANNETTE·Filed 2007·Application pending·0 cites
- 2346US11672863B2Enhanced solubility drug-containing formulationsUNITED THERAPEUTICS CORP·Filed 2018·Granted Jun 13, 2023·0 cites·24 claims
- 2439US2006019933A1Process for preparing stabilized vitamin DBOARDMAN DAVID·Filed 2005·Application pending·0 cites
- 2537US2007298099A1Liquid and Semi-Solid Pharmaceutical Formulations for Oral Administration of a Substituted AmidePERESYPKIN ANDREY V·Filed 2005·Application pending·0 cites
- 2635US2005165000A1Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactantFiled 2003·Application pending·0 cites
- 2733US6645961B1Dry granulation formulation for an HIV protease inhibitorMERCK & CO INC·Filed 1998·Granted Nov 11, 2003·2 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Drazen Ostovic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →